Nantahala Capital Management, Llc Portfolio Stock Holdings
According to the SEC 13F filed on August 19, 2026, Nantahala Capital Management, Llc disclosed 120 stock positions valued at approximately $1.66B as of quarter-end June 30, 2026. The largest holdings include BANCORP INC DEL, BIOVENTUS INC, and HILTON GRAND VACATIONS INC.
- Report Period
- June 30, 2026
- No. of Stocks
- 120
- Portfolio Value
- $1.66B
Holdings by Sector
Nantahala Capital Management, Llc Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| BANCORP INC DEL | TBBK | Financial Services | 4.69% | 1,239,887 | -140,569 | -10.18% | $77,666,522 |
| BIOVENTUS INC | BVS | Healthcare | 3.42% | 6,000,279 | -122,124 | -1.99% | $56,642,634 |
| HILTON GRAND VACATIONS INC | HGV | Consumer Cyclical | 3.27% | 1,033,170 | -480,486 | -31.74% | $54,107,113 |
| SAVARA INC | SVRA | Healthcare | 2.60% | 6,976,810 | -367,973 | -5.01% | $42,977,150 |
| ETON PHARMACEUTICALS INC | ETON | Healthcare | 2.57% | 1,175,951 | - | - | $42,569,426 |
| AMNEAL PHARMACEUTICALS INC | AMRX | Healthcare | 2.37% | 2,268,751 | -575,357 | -20.23% | $39,272,080 |
| EVOLUS INC | EOLS | Healthcare | 2.35% | 5,602,021 | -774,836 | -12.15% | $38,878,026 |
| AVALO THERAPEUTICS INC | AVTX | Healthcare | 2.08% | 1,862,250 | +627,250 | +50.79% | $34,414,380 |
| LB PHARMACEUTICALS INC | LBRX | Other | 2.06% | 1,052,894 | - | - | $34,171,675 |
| ANTERIS TECHNOLOGIES GLOBAL | AVR | Other | 2.01% | 3,383,335 | -2,147,575 | -38.83% | $33,325,850 |
| ABEONA THERAPEUTICS INC | ABEO | Healthcare | 1.92% | 5,136,490 | +123,438 | +2.46% | $31,743,508 |
| PELOTON INTERACTIVE INC | PTON | Consumer Cyclical | 1.82% | 5,108,995 | -6,891,005 | -57.43% | $30,194,160 |
| ESTABLISHMENT LABS HLDGS INC | ESTA | Other | 1.74% | 335,830 | -497,126 | -59.68% | $28,817,572 |
| XTANT MED HLDGS INC | XTNT | Healthcare | 1.74% | 68,394,000 | - | - | $28,793,874 |
| JACK IN THE BOX INC | JACK | Consumer Cyclical | 1.65% | 1,728,659 | +185,944 | +12.05% | $27,330,099 |
| GOGO INC | GOGO | Communication Services | 1.63% | 8,697,731 | -184,305 | -2.08% | $26,962,966 |
| IMAX CORP | IMAX | Communication Services | 1.58% | 658,009 | +142,455 | +27.63% | $26,228,239 |
| ZEVRA THERAPEUTICS INC | ZVRA | Healthcare | 1.56% | 1,797,476 | -724,460 | -28.73% | $25,775,806 |
| TITAN MACHY INC | TITN | Industrials | 1.45% | 1,133,088 | -121,432 | -9.68% | $23,930,819 |
| RMR GROUP INC | RMR | Real Estate | 1.42% | 1,147,902 | - | - | $23,566,428 |
| FOSSIL GROUP INC | FOSL | Consumer Cyclical | 1.38% | 5,505,128 | +101,104 | +1.87% | $22,791,230 |
| FOX FACTORY HLDG CORP | FOXF | Consumer Cyclical | 1.34% | 1,310,695 | -177,605 | -11.93% | $22,209,727 |
| MINERALYS THERAPEUTICS INC | MLYS | Healthcare | 1.34% | 820,481 | -75,000 | -8.38% | $22,136,577 |
| RIDENOW GROUP INC | RMBL | Consumer Cyclical | 1.32% | 3,272,845 | - | - | $21,797,148 |
| UNIQURE NV | QURE | Other | 1.27% | 455,660 | +218,582 | +92.20% | $20,987,700 |
| AURA BIOSCIENCES INC | AURA | Healthcare | 1.27% | 2,951,030 | +833,333 | +39.35% | $20,952,313 |
| AGOMAB THERAPEUTICS NV | AGMB | Other | 1.23% | 1,568,188 | +368,188 | +30.68% | $20,355,080 |
| FULCRUM THERAPEUTICS INC | FULC | Healthcare | 1.21% | 5,475,040 | +2,425,000 | +79.51% | $20,038,646 |
| BENITEC BIOPHARMA INC | BNTC | Healthcare | 1.20% | 1,488,371 | +50,000 | +3.48% | $19,914,404 |
| ADMA BIOLOGICS INC | ADMA | Healthcare | 1.19% | 2,359,993 | +2,359,993 | +100.00% | $19,753,141 |
Showing 30 of 120 holdings in the latest reporting period.
Nantahala Capital Management, Llc Options Holdings in Q2 2026
| Quarter | Symbol | Company | Option | Contracts | Notional Value |
|---|---|---|---|---|---|
| Q2 2026 | IWM | iShares Russell 2000 ETF | PUT | 2,000,000 | $600,900,000 |
| Q2 2026 | PTON | Peloton Interactive, Inc. | CALL | 16,438,900 | $97,153,899 |
| Q2 2026 | HLF | Herbalife | CALL | 6,600,000 | $86,790,000 |
| Q2 2026 | VTRS | Viatris Inc. | CALL | 5,000,000 | $79,400,000 |
| Q2 2026 | EW | Edwards Lifesciences Corporatio | PUT | 800,000 | $72,368,000 |
| Q2 2026 | XBI | SPDR Series Trust SPDR S&P Bio | PUT | 400,000 | $63,300,000 |
| Q2 2026 | HGV | Hilton Grand Vacations Inc. | CALL | 1,075,000 | $56,297,750 |
| Q2 2026 | QTUM | Defiance Quantum ETF | PUT | 223,000 | $36,879,740 |
| Q2 2026 | QURE | uniQure N.V. | CALL | 800,000 | $36,848,000 |
| Q2 2026 | NBIX | Neurocrine Biosciences, Inc. | CALL | 200,000 | $33,707,000 |
| Q2 2026 | PRAX | Praxis Precision Medicines, Inc | PUT | 100,000 | $33,479,000 |
| Q2 2026 | KRYS | Krystal Biotech, Inc. | PUT | 85,000 | $31,591,950 |
| Q2 2026 | REGN | Regeneron Pharmaceuticals, Inc. | CALL | 40,000 | $24,941,600 |
| Q2 2026 | SNAP | Snap Inc. | CALL | 4,800,000 | $21,312,000 |
| Q2 2026 | CWH | Camping World Holdings, Inc. | CALL | 2,000,000 | $15,260,000 |
| Q2 2026 | FOXF | Fox Factory Holding Corp. | CALL | 800,000 | $13,556,000 |
| Q2 2026 | CHYM | Chime Financial | CALL | 600,000 | $12,288,000 |
| Q2 2026 | RMBL | RumbleOn, Inc. | CALL | 1,700,000 | $11,322,000 |
| Q2 2026 | RH | RH | CALL | 50,000 | $8,236,500 |
| Q2 2026 | TBBK | The Bancorp, Inc. | CALL | 125,800 | $7,880,112 |
| Q2 2026 | QURE | uniQure N.V. | PUT | 161,500 | $7,438,690 |
| Q2 2026 | ABEO | Abeona Therapeutics Inc. | CALL | 1,020,000 | $6,303,600 |
| Q2 2026 | PCVX | Vaxcyte, Inc. | CALL | 35,200 | $2,046,176 |
Showing 23 of 23 options positions in the latest reporting period.
Notional value represents the total exposure of the options position.